Body composition improvements become visible on body composition analysis between weeks eight and twelve
11 Both medicine classes can be used together with likely additive benefits, however, dual treatment with empagliflozin and a GLP-1 receptor agonist is not funded, except in heart failure
Chen YM, Li ZX, Zhang HY, Chen HX, Hao JF, Liu HF, et al
Targets multiple pathways: blood sugar, appetite, energy, fat metabolism Includes 4 patented, clinically studied ingredients Easy to take capsules No synthetic hormones Under $80 a month See the clinical studies: Everything else you need to know What is GLP-1 and why does it matter